Evidence map›Paper›PMID 42736350›Full record

ArticleMolecular psychiatry2026

Prevalent and characteristic alterations in blood-brain transcriptomic-functional imaging coupling in schizophrenia.

Yu-Sha Ji, Yi-Feng Liu, Zhi-Qiang Mu, Liu Fang-Fang, Miao-Yan Liu, Min Liu, Jia-Ni Zhao, Wen-Jun Wu, Di Wu, Ya-Hong Zhang and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Yu-Sha Ji *Department of Clinical Laboratory, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
Yi-Feng Liu *Shaanxi Provincial Key Laboratory of Clinical Genetic, School of Basic Medicine; Fourth Military Medical University, Xi'an, China.
Zhi-Qiang Mu *Department of Clinical Laboratory, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
Liu Fang-Fang *Department of Neurobiology, Fourth Military Medical University, Xi'an, China.
Miao-Yan LiuShaanxi Provincial Key Laboratory of Clinical Genetic, School of Basic Medicine; Fourth Military Medical University, Xi'an, China.
Min LiuDepartment of Radiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Jia-Ni ZhaoDepartment of Radiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Wen-Jun WuDepartment of Psychiatry, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Di WuDepartment of Psychiatry, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Ya-Hong ZhangDepartment of Psychiatry, Xi'an Gaoxin Hospital, Xi'an, China.
Xiao-Hui LiDepartment of Radiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yong-Bin WeiSchool of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing, China.ORCID http://orcid.org/0000-0002-8044-7667
Fang-Lin GuanKey Laboratory of National Health Commission for Forensic Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.
Yue-Lang ZhangDepartment of Radiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Hua-Ning WangDepartment of Psychiatry, Xijing Hospital, Fourth Military Medical University, Xi'an, China.ORCID http://orcid.org/0000-0003-1981-4293
Kun ChenDepartment of Anatomy, Histology and Embryology and K.K. Leung Brain Research Center, Fourth Military Medical University, Xi'an, China. chenkun@fmmu.edu.cn.ORCID http://orcid.org/0000-0002-4433-127X
Long-Biao CuiShaanxi Provincial Key Laboratory of Clinical Genetic, School of Basic Medicine; Fourth Military Medical University, Xi'an, China. lbcui@fmmu.edu.cn.ORCID http://orcid.org/0000-0002-0784-181X
An-An YinShaanxi Provincial Key Laboratory of Clinical Genetic, School of Basic Medicine; Fourth Military Medical University, Xi'an, China. yinanan@aliyun.com.ORCID http://orcid.org/0000-0002-1888-5551
Yuan-Ming WuDepartment of Clinical Laboratory, Tangdu Hospital, Fourth Military Medical University, Xi'an, China. wuym@fmmu.edu.cn.ORCID http://orcid.org/0000-0002-5276-4382

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82572176
6 · The paper itself

Abstract

Schizophrenia (SCZ) is increasingly recognized as a multi-system disorder characterized by peripheral immunometabolic dysregulation. To investigate system-level blood-brain integration, we analyzed peripheral blood transcriptomics, resting-state fMRI (fALFF), and cognitive data from two cohorts (Discovery: 43 SCZ, 60 HCs; Validation: 41 SCZ, 29 HCs). Seven robust peripheral blood gene co-expression modules associated with SCZ were identified, enriched for immune and metabolic pathways. These modules showed reproducible disease associations in independent blood cohorts. Widespread alterations in functional coupling between these gene modules and intrinsic brain activity (fALFF) were observed in SCZ, characterized by a network-specific reconfiguration with an inverse pattern of correlation changes between limbic and frontoparietal/default mode networks. This dysregulated coupling pattern was highly reproducible across cohorts. We further identified putative core disease-associated module-network pairs: a downregulated metabolic module coupled with frontoparietal/default mode regions, and an upregulated ribosomal module coupled with limbic regions. Integration of these multimodal features yielded a proof-of-concept improvement in SCZ diagnostic classification (AUCs: 0.71-0.77 in an independent temporal but local validation cohort). Correlation and mediation analyses suggested that brain functional activity in these coupled regions may mediate the relationship between peripheral gene expression and cognitive impairment. Collectively, these findings reveal distinct, reproducible dysregulation of peripheral-central functional coupling in SCZ, offering a multi-scale framework for understanding its pathophysiology and highlighting the potential of trans-scale features as candidate biomarkers for diagnosis and mechanistic insight.

Identifiers

PMID42736350

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.